INTRODUCTION
============

Obstructive ileocolitis is an ulcero-inflammatory lesion proximal to an obstructive colorectal lesion \[[@b1-ac-2017-06-14-1]\]. As the name implies, both the ileum and colon can be involved in this condition. Excessive pressure due to distension of the bowel leading to ischemia has been proposed as the possible underlying pathophysiologic process \[[@b2-ac-2017-06-14-1]\]. Not surprisingly, the cecum is the most likely location at which this condition often manifests itself \[[@b3-ac-2017-06-14-1]\]. Ulcero-inflammatory lesions can take the form of ulcers, perforations or features of ischemia, such as gangrene.

When obstructive ileocolitis presents itself, management to relieve the obstruction should be initiated immediately as further delays could result in worsening ischemia and eventual perforation, which increases perioperative morbidity and mortality significantly \[[@b4-ac-2017-06-14-1]\]. Therefore, a need exists to identify these patients early and to expedite interventions to relieve the obstruction. The aim of this study was to identify factors that could be associated with obstructive ileocolitis by matching patients with obstructed colorectal cancer with obstructive ileocolitis with a similar cohort of patients with obstructed colorectal cancers but without obstructive ileocolitis.

METHODS
=======

Between November 2005 to June 2015, 21 patients (cases) with obstructive ileocolitis presented with intestinal obstruction secondary to colorectal cancers Obstructive ileocolitis was defined as histologic findings of ulcers, ischemia, gangrene or perforations of either the large or the small bowel. These cases were then matched on a 1:1 ratio for age and gender to patients with obstructed colorectal cancers but without obstructive ileocolitis (the controls). In the controls, the mucosa linings of the proximal colon were devoid of the aforementioned pathological features. This study was approved by the Institutional Review Board of the National University of Singapore. In view of the retrospective nature of this study, informed consent was deemed unnecessary by the Institutional Review Board.

Patient demographics, clinical findings on history taking and examination, and the results of pre-operative blood tests and radiological investigations were documented. Results were analyzed using Stata version 13.0, and P \< 0.05 was considered statistically significant. Univariate analyses were performed using the Wilcoxon matched-pairs signed-ranked test and the paired t-test for continuous variables and McNemar's exact test for categorical variables.

RESULTS
=======

The 21 patients identified with obstructive ileocolitis had a median age of 71 years (range, 52--86 years). About half of these patients had hypertension (57.1%) and hyperlipidemia (47.6%), with one-third suffering from diabetes (33.3%). The most common presenting symptom was abdominal pain (76.2%), followed by vomiting/nausea (66.7%), and abdominal distension (57.1%). [Table 1](#t1-ac-2017-06-14-1){ref-type="table"} shows the general profile of our study population. The location of abdominal pain appears to be varied, with roughly equal numbers of patients complaining of pain in the various quadrants of the abdomen, as shown in [Table 2](#t2-ac-2017-06-14-1){ref-type="table"}. Cases also generally presented with normal hemodynamic parameters and were afebrile (36.9°C ± 0.8°C). Cases were found to have a shorter time from scan to surgery (P = 0.046). This is likely a reflection of the prioritization given to them by the medical team for early surgery in view of an impending perforation as evidenced by high lactate and metabolic acidosis. [Table 3](#t3-ac-2017-06-14-1){ref-type="table"} shows that cases of obstructive ileocolitis had elevated total leucocyte count (17.1 ± 9.4×10^9^/L). Arterial blood gas analyses revealed low standardized bicarbonate (18.8 ± 4.5 mmol/L), low base excess (-6.53 ± 5.32 mmol/L), and high lactate (3.14 ± 2.19 mmol/L). Radiological features of proximal bowel dilatation, collapsed distal bowel, and small bowel involvement were present in over half of these cases.

When the 21 cases were compared against the controls, no significant differences were observed in the prevalence of comorbidities, such as hypertension, diabetes or hyperlipidemia. In addition, no significant differences in the duration of symptoms prior to presentation to the hospital were noted. Moreover, no specific symptoms or location of abdominal pain was associated with a higher likelihood of developing obstructive ileocolitis. Traditional vital signs, such as heart rate, temperature and blood pressure, were also not predictive of obstructive ileocolitis. Compared to the controls, cases were found to have a significantly higher total leucocyte count (17.1 ± 9.4×10^9^/L vs. 12.0 ± 6.8×10^9^/L, P = 0.016), lower pCO~2~ (32.3 ± 8.2 mmHg vs. 34.8 ± 4.9 mmHg, P = 0.013), lower HCO~3~ (18.8 ± 4.5 mmol/L vs. 23.6 ± 2.7 mmol/L, P \< 0.001), lower base excess (-6.53 ± 5.32 mmol/L vs. -0.57 ± 2.99 mmol/L, P \< 0.001) and higher lactate (3.14 ± 2.19 mmol/L vs. 1.19 ± 0.91 mmol/L, P = 0.007) ([Table 3](#t3-ac-2017-06-14-1){ref-type="table"}). No radiological features were noted to be predictive of obstructive ileocolitis.

[Table 4](#t4-ac-2017-06-14-1){ref-type="table"} shows our study population's tumor characteristics as reported on histology. No statistically significant differences were found. Most of our cases of obstructive ileocolitis had ulceration noted on histology (76.2%), half had evidence of bowel ischemia (52.4%), and only 1 (4.8%) presented with perforation. [Table 5](#t5-ac-2017-06-14-1){ref-type="table"} shows the Clavien-Dindo classification of cases compared to controls. Interestingly, 4 deaths occurred among the controls compared to none among cases, although drawing any significant conclusion is difficult as the study was not designed for this comparison.

DISCUSSION
==========

Our findings suggest that laboratory investigations are perhaps the most useful factor in identifying patients with obstructive ileocolitis when presenting with obstructed colorectal cancer. Interestingly, radiological findings were not associated with obstructive ileocolitis. The presence of high serum lactate, metabolic acidosis with respiratory compensation, and higher leukocytosis were associated with obstructive ileocolitis. Not surprisingly, raised serum lactate with associated metabolic acidosis is also seen in patients with an ischemic bowel \[[@b5-ac-2017-06-14-1]\]. This would suggest a similar pathophysiology that would account for the clinical and the biochemical features seen in obstructive ileocolitis. In essence, the decreased tissue perfusion leads to increased anaerobic respiration, which then results in increased formation of lactic acid from pyruvate. Intestinal injury occurs when a persistently low tissue perfusion state leads to insufficient delivery of oxygen and nutrients required for cellular metabolism. This can be exacerbated by reperfusion injury, a complex response characterized by the release of free radicals and toxic by-products of ischemic injury. In the acute state, respiratory compensation of metabolic acidosis occurs by hyperventilation in a bid to reduce PaCO~2~.

Moving away from biochemical investigations, computed tomographic scans are commonplace and have become indispensable in the field of surgical practice. Interestingly, in our small series, computed tomography scans did not appear to be helpful in identifying patients with obstructive ileocolitis. This could be because the ulcero-inflammatory changes that underlie the pathogenesis of obstructive ileocolitis start at the tissue level, a level too small in scale to be picked up by radiological imaging and/or because obvious radiological features such as pneumatosis intestinalis take time to develop. Certain radiological features, such as poor enhancement of the bowel wall in the clinical context of metabolic acidosis with high lactate, should still alert the clinician to the possibility of an ischemic bowel, which can occur in cases of obstructive ileocolitis. However, the authors urge caution in interpreting all cases of pneumatosis intestinalis as definite evidence of an ischemic bowel as our earlier publication disputed this relationship \[[@b6-ac-2017-06-14-1]\]. To our knowledge, no prior study has conclusively proven that obstructive ileocolitis can be treated conservatively. Hence, when obstructive ileocolitis is suspected, appropriate and expeditious intervention should be adopted to relieve the obstruction. Should the ischemia continue to worsen, gangrene will likely occur, and perforation is inevitable. Surgery in such instances is fraught with abysmal morbidity and mortality rates.

The authors recognize that this study has several limitations, with main issues being that the small size of the studied population and the biases associated with a retrospective review. However, we hope that these biases were mitigated by our matching the cases with appropriate controls. The varied timings at which the radiological and serological investigations occurred were also not controlled. Moving ahead, as the interest in endoscopic stenting and minimally invasive surgery to relieve an obstruction continues to gain in popularity, an ongoing need exists to verify our findings in future larger scale studies. Only then can we initiate expeditious interventions to relieve obstructions in those at significant risks of developing worsening ischemia and ensuing perforation.

In summary, patients presenting with obstructed colorectal cancers with high lactate and metabolic acidosis with respiratory compensation should be suspected of harboring underlying obstructive ileocolitis. In these patients, expeditious relief of the obstruction is critical.
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###### 

Comparison of patients' characteristics between cases and controls

  Characteristic                Case (n = 21)   Control (n = 21)   P-value
  ----------------------------- --------------- ------------------ ---------
  Age (yr)                      71 (52-86)      68 (50-87)         \-
  Sex                                                              \-
   Male                         10 (47.6)       10 (47.6)          
   Female                       11 (52.4)       11 (52.4)          
  Ethnicity                                                        \-
   Chinese                      10 (47.6)       19 (90.5)          
   Malay                        8 (38.1)        2 (9.5)            
   Indian                       0 (0)           0 (0)              
   Others                       3 (14.3)        0 (0)              
  Patient comorbidities                                            
   Diabetes mellitus            7 (33.3)        5 (23.8)           0.774
   Hypertension                 12 (57.1)       10 (47.6)          0.754
   Hyperlipidemia               10 (47.6)       7 (33.3)           0.607
   Stroke                       3 (14.3)        0 (0)              0.250
   Ischemic heart disease       3 (14.3)        5 (23.8)           0.625
   Colonic diverticulum         0 (0)           1 (4.8)            0.999
   Previous abdominal surgery   3 (14.3)        3 (15.0)           0.999
   Smoker                       2 (12.5)        2 (20.0)           0.999

Values are presented as median (range) or number (%).

###### 

Comparison of clinical presentations between cases and controls

  Variable                         Case (n = 21)   Control (n = 21)   P-value
  -------------------------------- --------------- ------------------ ---------
  Duration of symptoms (day)       3.5 (2.5-6)     4 (2-14)           0.549
  Symptoms                                                            
   Abdominal pain                  16 (76.2)       18 (85.7)          0.727
   Vomiting/nausea                 14 (66.7)       12 (57.1)          0.999
   Abdominal distension            12 (57.1)       16 (76.2)          0.219
   Constipation                    11 (52.4)       12 (57.1)          0.625
   Rectal bleeding                 1 (4.8)         1 (4.8)            0.999
  Location of abdominal pain                                          
   Generalized                     7 (33.3)        7 (33.3)           0.999
   Epigastrium                     9 (42.9)        10 (47.6)          0.999
   Right iliac fossa               9 (42.9)        10 (47.6)          0.774
   Left iliac fossa                8 (38.1)        13 (61.9)          0.180
   Left hypochondrium              8 (38.1)        8 (38.1)           0.999
   Umbilical                       9 (42.9)        8 (38.1)           0.999
  Parameters                                                          
   Systolic blood pressure         130.4 ± 37.9    132.9 ± 16.8       0.718
   Diastolic blood pressure        70.3 ± 15.4     77.0 ± 9.4         0.141
   Heart rate                      91.2 ± 20.1     90.1 ± 11.8        0.794
   Respiratory rate                17.7 ± 1.2      17.8 ± 1.1         0.600
   Temperature                     36.9 ± 0.8      36.7 ± 0.6         0.388
  Time from scan to surgery (hr)   9.3 ± 5.9       28.8 ± 27.5        0.046
  Neo-adjuvant chemoradiotherapy                                      
   Preoperative chemotherapy       1 (4.8)         0 (0)              0.999
   Preoperative radiotherapy       0 (0)           0 (0)              0.999

Values are presented as median (interquartile range), number (%), or mean ± standard deviation.

###### 

Comparison of laboratory parameters and computed tomography features between cases and controls

  Variable                              Case (n = 21)   Control (n = 21)   P-value
  ------------------------------------- --------------- ------------------ ---------
  Hemoglobin (g/dL)                     11.3 ± 3.0      11.6 ± 2.7         0.627
  Hematocrit (%)                        34.9 ± 7.8      35.3 ± 6.4         0.718
  Total leucocyte count (×10^9^/L)      17.1 ± 9.4      12.0 ± 6.8         0.016
  Platelets (×10^9^/L)                  406.6 ± 128.8   367.8 ± 117.3      0.387
  Urea (mmol/L)                         8.6 ± 5.9       7.2 ± 7.8          0.549
  Creatinine (pmol/L)                   133.6 ± 149.9   76.2 ± 33.0        0.105
  Carcinogen embryonic antigen (pg/L)   30.7 ± 37.3     252.4 ± 540.7      0.193
  pH                                    7.37 ± 0.10     7.17 ± 0.87        0.538
  pCO~2~ (mmHg)                         32.3 ± 8.2      34.8 ± 4.9         0.013
  HCO~3~ (standard) (mmol/L)            18.8 ± 4.5      23.6 ± 2.7         \<0.001
  Base excess (mmol/L)                  -6.53 ± 5.32    -0.57 ± 2.99       \<0.001
  Lactate (mmol/L)                      3.14 ± 2.19     1.19 ± 0.91        0.007
  Glucose (mmol/L)                      8.4 ± 3.0       7.2 ± 1.9          0.072
  CT evidence of                                                           
   Proximal bowel dilatation            16 (76.2)       20 (95.2)          0.250
   Cecal wall oedema/pneumatosis        2 (9.5)         2 (9.5)            0.999
   Collapsed bowel distally             13 (61.9)       8 (38.1)           0.289
   Small bowel involvement              12 (57.1)       14 (66.7)          0.375
   Closed loop                          2 (9.5)         6 (28.6)           0.625
   Metastatic disease                   3 (14.3)        1 (4.8)            0.999

Values are presented as mean ± standard deviation or number (%).

###### 

Comparison of the tumors' characteristics between cases and controls

  Variable                                                           Case (n = 21)   Control (n = 21)   P-value
  ------------------------------------------------------------------ --------------- ------------------ ---------
  Tumor location[^a)^](#tfn1-ac-2017-06-14-1){ref-type="table-fn"}                                      \-
  Right colon                                                        9 (42.9)        12 (57.1)          
  Left colon                                                         9 (42.9)        9 (42.9)           
  Rectum                                                             3 (14.3)        0 (0)              
  Tumor size (cm)                                                    4.65 ± 1.43     4.96 ± 1.94        0.697
  T stage                                                                                               \-
   4                                                                 11 (52.4)       11 (52.4)          
   3                                                                 9 (42.9)        9 (42.9)           
   2                                                                 0 (0)           0 (0)              
   1                                                                 0 (0)           0 (0)              
  N stage                                                                                               \-
   2                                                                 7 (33.3)        6 (28.6)           
   1                                                                 7 (33.3)        8 (38.1)           
   0                                                                 6 (28.6)        6 (28.6)           
  Metastatic disease                                                 3 (14.3)        4 (19.0)           0.999
  Colon maximum diameter (cm)\*                                      12.3 ± 3.9      8.6 ± 3.6          0.080
  Obstructive ileocolitis in                                                                            \-
   Small bowel                                                       4 (19.0)        NA                 
   Large bowel                                                       17 (81.0)       \-                 
  Obstructive ileocolitis with                                                                          \-
   Proximal bowel ulceration                                         16 (76.2)       NA                 
   Proximal bowel ischemia                                           11 (52.4)       NA                 
   Proximal bowel perforation                                        1 (4.8)         NA                 
   Ischemia at caecum                                                4 (19.0)        NA                 
   Perforation at caecum                                             1 (4.8)         NA                 

Values are presented as number (%) or mean ± standard deviation.

NA, not available.

Right colon, cecum to transverse colon; left colon, splenic flexure to sigmoid colon.

###### 

Comparison of surgical complications between cases and controls

  Clavien-Dindo classification   Case (n = 21)   Control (n = 21)
  ------------------------------ --------------- ------------------
  No complications               15 (71.4)       13 (61.9)
   I                             4 (19.0)        3 (14.3)
   II                            0 (0)           1 (4.8)
   III                           1 (4.8)         0 (0)
   IV                            1 (4.8)         0 (0)
   V                             0 (0)           4 (19.0)

Values are presented as number (%).
